Also trades as: 0867.HK (HKSE) · $vol 9M · 2M7C.F (FSX) · $vol 0M

$1.57

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 58 · $3.8B mcap · 1.18B float · 0.0000% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$8.0B +7.1% ▲

5Y CAGR: +2.9%

Gross Profit

$5.7B +5.5% ▲

5Y CAGR: +2.2%

Operating Income

$1.5B -11.2% ▼

5Y CAGR: -11.1%

Net Income

$1.5B -10.5% ▼

5Y CAGR: -10.5%

EPS (Diluted)

$0.60 -10.4% ▼

5Y CAGR: -10.1%

EBITDA

$1.8B -22.1% ▼

5Y CAGR: -10.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$8.3B	$9.2B	$8.0B	$7.5B	$8.0B
YoY Growth	+20.0%	+9.8%	-12.4%	-6.8%	+7.1%
Cost of Revenue	$2.1B	$2.1B	$1.9B	$2.0B	$2.3B
Gross Profit	$6.2B	$7.0B	$6.1B	$5.4B	$5.7B
Gross Margin	74.9%	76.9%	75.8%	72.6%	71.5%
R&D Expenses	$115M	$125M	$195M	$330M	$570M
SG&A Expenses	$3.0B	$3.4B	$3.2B	$3.4B	$3.6B
Operating Expenses	$3.0B	$3.4B	$3.4B	$3.7B	$4.2B
Operating Income	$3.2B	$3.6B	$2.7B	$1.7B	$1.5B
Operating Margin	37.8%	38.8%	33.9%	23.2%	19.2%
Interest Expense	$28M	$49M	$46M	$39M	$20M
Income Before Tax	$3.5B	$3.8B	$2.9B	$2.0B	$2.0B
Tax Expense	$431M	$487M	$489M	$397M	$643M
Net Income	$3.0B	$3.3B	$2.4B	$1.6B	$1.5B
Net Margin	36.2%	35.6%	30.0%	21.7%	18.1%
EPS (Diluted)	$1.22	$1.33	$0.98	$0.67	$0.60
EBITDA	$3.7B	$3.8B	$2.9B	$2.3B	$1.8B
Shares Outstanding	2.47B	2.45B	2.45B	2.43B	2.42B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$4.7B	$4.6B	$3.4B	$3.6B	$3.9B	$4.0B	$4.1B	$4.4B
Cost of Revenue	$1.1B	$1.0B	$933M	$915M	$1.1B	$1.1B	$1.2B	$1.3B
Gross Profit	$3.6B	$3.6B	$2.5B	$2.7B	$2.7B	$2.9B	$2.9B	$3.2B
Gross Margin	76.5%	78.2%	72.6%	74.7%	70.7%	72.3%	70.8%	71.6%
R&D Expenses	$70M	$76M	$119M	$106M	$224M	$202M	$376M	$352M
SG&A Expenses	$1.8B	$1.7B	$1.5B	$1.8B	$1.7B	$1.9B	$1.8B	$1.8B
Operating Expenses	$1.9B	$1.4B	$1.6B	$1.9B	$1.8B	$2.1B	$2.2B	$2.2B
Operating Income	$1.7B	$1.9B	$840M	$829M	$904M	$834M	$732M	$979M
Operating Margin	36.8%	40.6%	24.7%	23.0%	23.4%	20.8%	17.7%	22.1%
Interest Expense	$0	$0	$0	$0	$39M	$0	$9M	$8M
Income Before Tax	$1.7B	$2.3B	$591M	$1.1B	$874M	$1.1B	$943M	$1.2B
Tax Expense	$227M	$367M	$123M	$233M	$164M	$213M	$440M	$216M
Net Income	$1.5B	$1.9B	$480M	$910M	$709M	$941M	$539M	$973M
Net Margin	31.1%	41.7%	14.1%	25.2%	18.4%	23.5%	13.0%	21.9%
EPS (Diluted)	$0.60	$0.78	$0.20	$0.37	$0.29	$0.39	$0.22	$0.40
EBITDA	$1.8B	$2.0B	$946M	$943M	$1.4B	$939M	$875M	$1.1B
Shares Outstanding	2.45B	2.45B	2.45B	2.44B	2.43B	2.42B	2.42B	2.42B

CHSYF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet